Understanding how certain bacteria start protein production without traditional signals
Mechanism of Translation Initiation on Leaderless mRNAs
This study is looking at how certain types of mRNAs, which don't have the usual signals to start making proteins, are used by bacteria and archaea, especially Mycobacteria, to help us learn more about how these germs work and why some are resistant to antibiotics.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Auburn University at Auburn NIH-funded |
| Lab location | 1 site (Auburn, UNITED STATES) |
| Project ID | NIH-10738789 on NIH RePORTER |
What this research studies
This research investigates the unique process by which leaderless mRNAs, which lack conventional initiation signals, are translated in bacteria and archaea, particularly focusing on Mycobacteria. The study employs advanced single-molecule fluorescence techniques to observe the translation initiation process in real-time, allowing researchers to identify how these mRNAs interact with ribosomes and translation factors. By uncovering the mechanisms behind leaderless translation, the research aims to enhance our understanding of bacterial physiology and antibiotic resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with infections caused by Mycobacteria or other bacteria that utilize leaderless mRNAs.
Not a fit: Patients with infections caused by bacteria that do not utilize leaderless mRNAs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for combating antibiotic resistance in bacterial infections.
How similar studies have performed: While the specific mechanisms of leaderless mRNA translation are less understood, similar approaches in studying bacterial translation have shown promise in other contexts.
Where this research is happening
Auburn, UNITED STATES
- Auburn University at Auburn — Auburn, United States (Active)
Researchers
- Principal investigator: Petrov, Alexey — Auburn University at Auburn
- Study coordinator: Petrov, Alexey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.